Skip to main content
Erschienen in: Pediatric Nephrology 3/2018

15.10.2017 | Original Article

Immunohistochemical and serological characterization of membranous nephropathy in children and adolescents

verfasst von: Anne K. Dettmar, Thorsten Wiech, Markus J. Kemper, Armin Soave, Michael Rink, Jun Oh, Rolf A. K. Stahl, Elion Hoxha, for the Pediatric MN Study Group

Erschienen in: Pediatric Nephrology | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Membranous nephropathy (MN) is a common cause of nephrotic syndrome in adults, but is less frequent in children. Antibodies against four antigens leading to MN have been described in children: phospholipase A2 receptor 1 (PLA2R1), thrombospondin type-1 domain-containing 7A (THSD7A), neutral endopeptidase (NEP), and cationic bovine serum albumin (BSA).

Methods

Twelve children with MN were included in this study. Sera of all patients were analyzed for antibodies against PLA2R1, THSD7A, NEP, and BSA. All sera were also analyzed using Western blot with human glomerular extracts (HGE) under non reducing conditions. In 5 cases renal biopsies were analyzed for PLA2R1, THSD7A, NEP, BSA, and all IgG subclasses.

Results

Six patients were PLA2R1-antibody-positive, whereas THSD7A, NEP, and BSA antibodies were not found in any of our 12 patients. All sera were analyzed by Western blot using human glomerular extracts; however, no further potential antigens were found. Five kidney biopsies from 2 PLA2R1-antibody-positive and 3 PLA2R1-antibody-negative patients were available for additional analyses, confirming the diagnosis of PLA2R1-associated MN in 2 cases, whereas none of the biopsies revealed enhanced staining for THSD7A, NEP or BSA. IgG2 and IgG4 stainings were positive in both patients with PLA2R1-associated MN and negative in the other biopsies. During follow-up (median 24 months), 4 children with PLA2R1-associated MN went into remission, preceded by decline of PLA2R1 antibodies. Five of the 6 PLA2R1-antibody-negative children went into remission.

Conclusions

In children with MN, PLA2R1-associated MN appears to be common, whereas MN associated with THSD7A, NEP or BSA was not encountered. PLA2R1 antibody levels are closely associated with disease activity, whereas PLA2R1-antibody-negative patients often have a good prognosis. However, the pathophysiology of MN in a considerable number of children remains unclear.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ (2009) M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361:11–21CrossRefPubMedPubMedCentral Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ (2009) M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361:11–21CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Tomas NM, Beck LH Jr, Meyer-Schwesinger C, Seitz-Polski B, Ma H, Zahner G, Dolla G, Hoxha E, Helmchen U, Dabert-Gay AS, Debayle D, Merchant M, Klein J, Salant DJ, Stahl RA, Lambeau G (2014) Thromobospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N Engl J Med 371:2277–2287CrossRefPubMedPubMedCentral Tomas NM, Beck LH Jr, Meyer-Schwesinger C, Seitz-Polski B, Ma H, Zahner G, Dolla G, Hoxha E, Helmchen U, Dabert-Gay AS, Debayle D, Merchant M, Klein J, Salant DJ, Stahl RA, Lambeau G (2014) Thromobospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N Engl J Med 371:2277–2287CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Hoxha E, Beck LH Jr, Wiech T, Tomas NM, Probst C, Mindorf S, Meyer-Schwesinger C, Zahner G, Stahl PR, Schöpper R, Panzer U, Harendza S, Helmchen U, Salant DJ, Stahl RA (2017) An indirect immunofluorescence method facilitates detection of thrombospondin type 1 domain-containing 7A-specific antibodies in membranous nephropathy. J Am Soc Nephrol 28:520–531CrossRefPubMed Hoxha E, Beck LH Jr, Wiech T, Tomas NM, Probst C, Mindorf S, Meyer-Schwesinger C, Zahner G, Stahl PR, Schöpper R, Panzer U, Harendza S, Helmchen U, Salant DJ, Stahl RA (2017) An indirect immunofluorescence method facilitates detection of thrombospondin type 1 domain-containing 7A-specific antibodies in membranous nephropathy. J Am Soc Nephrol 28:520–531CrossRefPubMed
5.
Zurück zum Zitat Hoxha E, Kneißler U, Stege G, Zahner G, Thiele I, Panzer U, Harendza S, Helmchen UM, Stahl RA (2012) Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy. Kidney Int 82:797–804CrossRefPubMed Hoxha E, Kneißler U, Stege G, Zahner G, Thiele I, Panzer U, Harendza S, Helmchen UM, Stahl RA (2012) Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy. Kidney Int 82:797–804CrossRefPubMed
6.
Zurück zum Zitat Kanda S, Horita S, Yanagihara T, Shimizu A, Hattori M (2017) M-type phospholipase A2 receptor (PLA2R) glomerular staining in pediatric idiopathic membranous nephropathy. Pediatr Nephrol 32:713–717CrossRefPubMed Kanda S, Horita S, Yanagihara T, Shimizu A, Hattori M (2017) M-type phospholipase A2 receptor (PLA2R) glomerular staining in pediatric idiopathic membranous nephropathy. Pediatr Nephrol 32:713–717CrossRefPubMed
7.
Zurück zum Zitat De Vriese AS, Glassock RJ, Nath KA, Sethi S, Fervenza FC (2017) A proposal for a serology-based approach to membranous nephropathy. J Am Soc Nephrol 28:421–430CrossRefPubMed De Vriese AS, Glassock RJ, Nath KA, Sethi S, Fervenza FC (2017) A proposal for a serology-based approach to membranous nephropathy. J Am Soc Nephrol 28:421–430CrossRefPubMed
8.
Zurück zum Zitat Kumar V, Varma AK, Nada R, Ghosh RK, Suri D, Gupta A, Kumar V, Rathi M, Kohli HS, Jha V, Gupta KL, Ramachandran R (2017) Primary membranous nephropathy in adolescence a prospective study. Nephrology (Carlton) 22:678–683CrossRef Kumar V, Varma AK, Nada R, Ghosh RK, Suri D, Gupta A, Kumar V, Rathi M, Kohli HS, Jha V, Gupta KL, Ramachandran R (2017) Primary membranous nephropathy in adolescence a prospective study. Nephrology (Carlton) 22:678–683CrossRef
9.
Zurück zum Zitat Debiec H, Guigonis V, Mougenot B, Decobert F, Haymann JP, Bensman A, Deschênes G, Ronco PM (2002) Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med 346:2053–2060CrossRefPubMed Debiec H, Guigonis V, Mougenot B, Decobert F, Haymann JP, Bensman A, Deschênes G, Ronco PM (2002) Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med 346:2053–2060CrossRefPubMed
10.
Zurück zum Zitat Debiec H, Lefeu F, Kemper MJ, Niaudet P, Deschênes G, Remuzzi G, Ulinski T, Ronco P (2011) Early-childhood membranous nephropathy due to cationic bovine serum albumin. N Engl J Med 364:2101–2110CrossRefPubMed Debiec H, Lefeu F, Kemper MJ, Niaudet P, Deschênes G, Remuzzi G, Ulinski T, Ronco P (2011) Early-childhood membranous nephropathy due to cationic bovine serum albumin. N Engl J Med 364:2101–2110CrossRefPubMed
11.
Zurück zum Zitat Menon S, Valentini RP (2010) Membranous nephropathy in children: clinical presentation and therapeutic approach. Pediatr Nephrol 25:1419–1428CrossRefPubMed Menon S, Valentini RP (2010) Membranous nephropathy in children: clinical presentation and therapeutic approach. Pediatr Nephrol 25:1419–1428CrossRefPubMed
12.
Zurück zum Zitat Dähnrich C, Komorowski L, Probst C, Seitz-Polski B, Esnault V, Wetzels JF, Hofstra JM, Hoxha E, Stahl RA, Lambeau G, Stöcker W, Schlumberger W (2013) Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy. Clin Chim Acta 421:213–218CrossRefPubMed Dähnrich C, Komorowski L, Probst C, Seitz-Polski B, Esnault V, Wetzels JF, Hofstra JM, Hoxha E, Stahl RA, Lambeau G, Stöcker W, Schlumberger W (2013) Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy. Clin Chim Acta 421:213–218CrossRefPubMed
13.
Zurück zum Zitat Hoxha E, Thiele I, Zahner G, Panzer U, Harendza S, Stahl RA (2014) Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy. J Am Soc Nephrol 25:1357–1366CrossRefPubMedPubMedCentral Hoxha E, Thiele I, Zahner G, Panzer U, Harendza S, Stahl RA (2014) Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy. J Am Soc Nephrol 25:1357–1366CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Hofstra JM, Debiec H, Short CD, Pellé T, Kleta R, Mathieson PW, Ronco P, Brenchley PE, Wetzels JF (2012) Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy. J Am Soc Nephrol 23:1735–1743CrossRefPubMedPubMedCentral Hofstra JM, Debiec H, Short CD, Pellé T, Kleta R, Mathieson PW, Ronco P, Brenchley PE, Wetzels JF (2012) Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy. J Am Soc Nephrol 23:1735–1743CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Ramachandran R, Kumar V, Nada R, Jha V (2015) Serial monitoring of anti-PLA2R in initial PLA2R-negative patients with primary membranous nephropathy. Kidney Int 88:1198–1199CrossRefPubMed Ramachandran R, Kumar V, Nada R, Jha V (2015) Serial monitoring of anti-PLA2R in initial PLA2R-negative patients with primary membranous nephropathy. Kidney Int 88:1198–1199CrossRefPubMed
16.
Zurück zum Zitat Van de Logt AE, Hofstra JM, Wetzels JF (2015) Serum anti-PLA2R antibodies can be initially absent in idiopathic membranous nephropathy: seroconversion after prolonged follow-up. Kidney Int 87:1263–1264CrossRefPubMed Van de Logt AE, Hofstra JM, Wetzels JF (2015) Serum anti-PLA2R antibodies can be initially absent in idiopathic membranous nephropathy: seroconversion after prolonged follow-up. Kidney Int 87:1263–1264CrossRefPubMed
Metadaten
Titel
Immunohistochemical and serological characterization of membranous nephropathy in children and adolescents
verfasst von
Anne K. Dettmar
Thorsten Wiech
Markus J. Kemper
Armin Soave
Michael Rink
Jun Oh
Rolf A. K. Stahl
Elion Hoxha
for the Pediatric MN Study Group
Publikationsdatum
15.10.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 3/2018
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-017-3817-y

Weitere Artikel der Ausgabe 3/2018

Pediatric Nephrology 3/2018 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.